• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Public-Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals.

作者信息

Mishra Poonam, Florian Jeffry, Peter Joy, Vainorius Monika, Fried Michael W, Nelson David R, Birnkrant Debra

机构信息

US Food and Drug Administration, Silver Spring, Maryland.

University of Florida, Gainesville, Florida.

出版信息

Gastroenterology. 2017 Sep;153(3):626-631. doi: 10.1053/j.gastro.2017.07.025. Epub 2017 Jul 27.

DOI:10.1053/j.gastro.2017.07.025
PMID:28757271
Abstract
摘要

相似文献

1
Public-Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals.公私合作伙伴关系：以丙型肝炎直接抗病毒药物的真实世界数据为目标
Gastroenterology. 2017 Sep;153(3):626-631. doi: 10.1053/j.gastro.2017.07.025. Epub 2017 Jul 27.
2
Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists.丙型肝炎病毒1型感染的治疗进展：来自传染病药剂师协会的见解
Pharmacotherapy. 2016 Feb;36(2):203-17. doi: 10.1002/phar.1700. Epub 2016 Feb 5.
3
Ribavirin and chronic hepatitis C infection.
FDA Consum. 2001 Sep-Oct;35(5):3.
4
Psychiatric care during hepatitis C treatment: the changing role of psychiatrists in the era of direct-acting antivirals.
Am J Psychiatry. 2015 Jun;172(6):512-6. doi: 10.1176/appi.ajp.2015.14081041.
5
A major advance in treating hepatitis C.丙型肝炎治疗方面的一项重大进展。
Johns Hopkins Med Lett Health After 50. 2011 Dec;23(10):6.
6
A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C.来迪派韦与索磷布韦的组合药物（夏帆宁）用于治疗丙型肝炎。
Med Lett Drugs Ther. 2014 Nov 10;56(1455):111-2.
7
[Pegasys: FDA approved Pegasys (peginterferon alfa-2a) for the treatment of hepatitis C].
Sidahora. 2002(4):8-10.
8
Ribavirin approved for hepatitis C combination treatment.
AIDS Treat News. 1998 Jun 19(No 297):7.
9
Detectable Viremia at the End of Treatment With Direct-Acting Antivirals Can Be Associated With Subsequent Clinical Cure in Patients With Chronic Hepatitis C: A Case Series.直接抗病毒药物治疗结束时可检测到的病毒血症可能与慢性丙型肝炎患者随后的临床治愈相关：病例系列报道
Gastroenterology. 2017 Oct;153(4):1165-1166. doi: 10.1053/j.gastro.2017.06.062. Epub 2017 Sep 4.
10
The changing landscape of adverse drug events associated with chronic hepatitis C virus therapy.
Expert Opin Drug Saf. 2015;14(11):1649-52. doi: 10.1517/14740338.2015.1088002. Epub 2015 Sep 12.

引用本文的文献

1
Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease.免疫调节剂联合维得利珠单抗或乌司奴单抗治疗炎症性肠病的应用现状。
Clin Transl Gastroenterol. 2023 Nov 1;14(11):e00620. doi: 10.14309/ctg.0000000000000620.
2
Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD.炎症性肠病患者真实世界观察性队列研究的方法与初步结果：TARGET-IBD研究
Crohns Colitis 360. 2021 May 13;3(3):otab023. doi: 10.1093/crocol/otab023. eCollection 2021 Jul.
3
Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infection.
评估机器学习算法在预测慢性丙型肝炎感染患者直接抗病毒治疗失败中的应用。
Sci Rep. 2022 Oct 27;12(1):18094. doi: 10.1038/s41598-022-22819-4.
4
Machine learning algorithms for predicting direct-acting antiviral treatment failure in chronic hepatitis C: An HCV-TARGET analysis.机器学习算法预测慢性丙型肝炎直接作用抗病毒治疗失败：HCV-TARGET 分析。
Hepatology. 2022 Aug;76(2):483-491. doi: 10.1002/hep.32347. Epub 2022 Feb 3.
5
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.一项关于口服抗病毒药物治疗慢性丙型肝炎的实用、随机对照临床试验：PRIORITIZE 研究。
Hepatology. 2021 Dec;74(6):2952-2964. doi: 10.1002/hep.32053. Epub 2021 Aug 26.
6
Integrating Real-World Evidence in the Regulatory Decision-Making Process: A Systematic Analysis of Experiences in the US, EU, and China Using a Logic Model.在监管决策过程中整合真实世界证据：使用逻辑模型对美国、欧盟和中国的经验进行系统分析。
Front Med (Lausanne). 2021 May 31;8:669509. doi: 10.3389/fmed.2021.669509. eCollection 2021.
7
International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale.国际特应性皮炎观察队列研究以追踪其自然病史和治疗过程：TARGET-DERM AD 研究设计和原理。
BMJ Open. 2020 Nov 27;10(11):e039928. doi: 10.1136/bmjopen-2020-039928.
8
Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation.《COVID-19 大流行及大流行后时代的肝脏病学临床研究：挑战与创新需求》
Hepatology. 2020 Nov;72(5):1819-1837. doi: 10.1002/hep.31491.
9
Computable Eligibility Criteria through Ontology-driven Data Access: A Case Study of Hepatitis C Virus Trials.通过本体驱动的数据访问实现可计算的资格标准：丙型肝炎病毒试验的案例研究
AMIA Annu Symp Proc. 2018 Dec 5;2018:1601-1610. eCollection 2018.
10
A real-world observational cohort of patients with primary biliary cholangitis: TARGET-primary biliary cholangitis study design and rationale.原发性胆汁性胆管炎患者的真实世界观察性队列研究：TARGET-原发性胆汁性胆管炎研究设计与原理
Hepatol Commun. 2018 Mar 23;2(5):484-491. doi: 10.1002/hep4.1173. eCollection 2018 May.